Searched for
CLARI5 ACQUISITION
- Indian startups raise $1.65 billion in February; median valuation at $83.2 millionIndian startups secured USD 1.65 billion in funding in February 2025, a 19.5% increase from January, though down year-on-year. Bengaluru le...
Perfios acquires healthcare information exchange platform IHXFounded in 2020, IHX connects healthcare providers and payors to facilitate real-time, digital-first claims processing across the healthcar...- B2B SaaS company Perfios acquires debt management firm CreditNirvanaPerfios has acquired debt management platform CreditNirvana, its second acquisition in a month. The deal strengthens its end-to-end financi...
- Indian startups raise $1.65 billion in February; median valuation at $83.2 millionThis brings the total funding in FY25 (April-February) to $25.4 billion, spread across 2,200 rounds, according to data from Traxcn. The Feb...
- Perfios acquires fraud detection platform Clari5Perfios acquired fraud detection platform Clari5 to enhance its fraud management capabilities. Clari5, with 200 employees, becomes a Perfio...
- Swiggy’s day out; banks on fraud patrolHappy Thursday! Swiggy delivered big on its market debut on Wednesday, leading to substantial gains for both early investors and employees....
- Baxter to acquire Claris Injectables for Rs 4,237 crore"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...
- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- With an aim of expansion, pharma companies like Lupin and Torrent eyeing overseas acquisitionThey are scouting for niche manufacturing sites, promising experimental drugs, specialty firms in emerging markets and opportunities in the...
- US market no longer a low hanging fruit, pharma cos go back to lab: Surajit Pal, Research Analyst, Prabhudas LilladherThe only way you can increase your US sales is by that acquisition in generics and keep on investing in R&D to get a product which will boo...
- Baxter emerges as frontrunner to buy KKR-backed Gland Pharma for $1.1-1.2 billionHyderabad-headquartered Gland is a leading contract manufacturers of injectables, supplying to pharma majors in India and US like Dr Reddy’...
- Sensex rallies 550 points; Nifty above 8,100; Tata Motors up 7%, HDFC gains 4%The S&P BSE Sensex surged over 500 points on Monday following positive trend across globe, especially the Asian and European markets.
- Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 croreBoth sides are currently engaged in last-minute due diligence negotiations involving tax and other financial matters, said at least five so...
- Nifty slips below 200-DMA; 16 stocks that lost upto 33% in last 10 daysThe benchmark Nifty index slipped below its 200-day moving average for the first time in nearly 15 months on Monday.
- Mitsui sets eyes on PM Narendra Modi’s pet infra, energy projects; sees big investment opportunities in IndiaMitsui is stepping up its focus on India, with a special eye on infrastructure development, energy and lifestyle as it seeks newer growth a...
- Mergers and acquisitions activities in India pick up pace across industriesEnding months of soul searching, Suzlon promoter Tulsi Tanti decided to lighten up Suzlon's stretched balance sheet by selling his German c...
- Gujarat's contribution surged in pharma, to become global hub: ASSOCHAMNearly 52K people are employed in Gujarat’s pharmaceutical sector, which has witnessed 54% CAGR in capital investments over the last three ...
- Carlyle hopes to break jinx with new India buyout bossPrivate equity investments in India doubled to $8 billion in 2010, from a year earlier. But there were hardly any buyouts.
- Strides eyes M&As for speciality pharma, R&DI-bankers, acting on behalf of Strides, have signalled M&A interest on part of the promoter group for its speciality pharma and R&D units.
- Carlyle raises $668mn for Asia growth fundGlobal private equity firm Carlyle has raised $668m for its latest Asia specific growth capital fund. The fund, called the Carlyle Asia Gro...
Load More
